HIV-1-infection Clinical Trials in Johannesburg
5 recruitingJohannesburg, South Africa
Showing 1–5 of 5 trials
Recruiting
Phase 2
Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children
HIV-1-infection
Gilead Sciences12 enrolled9 locationsNCT06749054
Recruiting
Phase 1Phase 2
Study of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living With HIV-1, Two to Less Than 12 Years of Age
HIV-1-infection
National Institute of Allergy and Infectious Diseases (NIAID)90 enrolled12 locationsNCT05660980
Recruiting
Phase 4
A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments
HIV-1-infection
Gilead Sciences350 enrolled14 locationsNCT06337032
Recruiting
Phase 1
Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Newborns Exposed to HIV
HIV-1-infection
Gilead Sciences16 enrolled7 locationsNCT07055451
Recruiting
Phase 2Phase 3
Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1
HIV-1-infection
Gilead Sciences75 enrolled21 locationsNCT06532656